CRBP - Corbus Pharmaceuticals Holdings Inc
IEX Last Trade
61.07
3.060 5.011%
Share volume: 392,556
Last Updated: Fri 30 Aug 2024 09:59:48 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$58.01
3.06
5.28%
Summary score
25%
Profitability
25%
Dept financing
10%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2017 - 31-Dec-2021
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-68.82%
Return on assets
-24.83%
Return on sales
-3880.61%
Return on invested capital
97.93%
Total debt ratio
46.02%
Debt ratio change over timeo
-0.83%
Current Ratio
3.62%
Quick Ratio
3.62%
Cash Position Ratio
3.42%
Short-term ratios 31-Dec-2020 - 31-Dec-2021
The data are presented for the financials results of the quarters of the last year.
Return on equity
-14.37%
Return on assets
-11.43%
Return on sales
-9622.15%
Return on invested capital
106.29%
Total debt ratio
35.45%
Debt ratio change over timeo
-0.44%
Current Ratio
5.97%
Quick Ratio
5.97%
Cash Position Ratio
5.73%
Last quarter ratios 31-Dec-2021
The data are presented for the financials results of the last quarter.
Return on equity
-14.85%
Return on assets
-9.28%
Return on sales
0%
Return on invested capital
108.21%
Total debt ratio
35.85%
Debt ratio change over time
-0.67%
Current Ratio
5.89%
Quick Ratio
5.89%
Cash Position Ratio
5.74%
Performance ratios (change over 4 years) 31-Dec-2017 - 31-Dec-2021
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-133.14%
Return on assets
-111.96%
Return on sales
-5787.45%
Return on invested capital
-36.23%
Total debt ratio
-82.53%
Debt ratio change over time
-0.83%
Current Ratio
2.58%
Quick Ratio
2.58%
Cash Position Ratio
2.36%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CRBP | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -68.82% | -6.12% | 17.44% | 8.57% |
| Return on assets | -24.83% | 3.34% | 3.74% | 6.3% |
| Return on sales | -3880.61% | 30.6% | 38.94% | 39.41% |
| Return on invested capital | 97.93% | 4.73% | 8.37% | 21.65% |
| Profitability | 25% | 34% | 67% | 68% |
| Total debt ratio | 46.02% | 100.81% | 83.14% | 28.81% |
| Debt ratio change over time | -0.83% | 265.19% | 10.81% | 1.15% |
| Dept financing | 11% | 50% | 22% | 7% |
| Current Ratio | 5.97% | 0.89% | 1.55% | 3.49% |
| Quick Ratio | 5.97% | 0.78% | 1.25% | 2.93% |
| Cash Position Ratio | 5.73% | 0.33% | 0.73% | 1.29% |
| Liquididy | 74% | 21% | 35% | 57% |
| Short-term ratios | CRBP | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.37% | 20.29% | 18.63% | 12.78% |
| Return on assets | -11.43% | 3.26% | 3.68% | 9.96% |
| Return on sales | -9622.15% | 34.28% | 35.24% | 53.66% |
| Return on invested capital | 106.29% | 3.23% | 5.33% | 37.78% |
| Profitability | 25% | 50% | 50% | 75% |
| Total debt ratio | 35.45% | 90.69% | 86.92% | 28.88% |
| Debt ratio change over time | -0.44% | 44.47% | 21.24% | -0.09% |
| Dept financing | 10% | 50% | 36% | 8% |
| Current Ratio | 5.97% | 0.89% | 1.55% | 3.49% |
| Quick Ratio | 5.97% | 0.78% | 1.25% | 2.93% |
| Cash Position Ratio | 5.73% | 0.33% | 0.73% | 1.29% |
| Liquididy | 75% | 8% | 15% | 33% |